Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
268.89
-4.36 (-1.60%)
Nov 2, 2026, 4:00 PM EST - Market closed
Tenet Healthcare Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, Tenet Healthcare stock has a consensus rating of "Buy" and an average price target of $301.59. The average 1-year stock price forecast is 12.16% higher than the current stock price, while the lowest is $265 (-1.45%) and the highest is $342 (+27.19%).
Price Target: $301.59 (+12.16%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tenet Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 14 | 14 | 14 | 14 |
| Buy | 6 | 6 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 3 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Reiterates $309 → $342 | Buy | Reiterates | $309 → $342 | +27.19% | Nov 2, 2026 |
| UBS | UBS | Buy Maintains $308 → $340 | Buy | Maintains | $308 → $340 | +26.45% | Nov 2, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $283 → $304 | Buy | Reiterates | $283 → $304 | +13.06% | Nov 2, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $263 → $302 | Buy | Maintains | $263 → $302 | +12.31% | Nov 2, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $290 → $305 | Buy | Maintains | $290 → $305 | +13.43% | Nov 2, 2026 |
Financial Forecast
Revenue This Year
22.46B
from 21.31B
Increased by 5.39%
Revenue Next Year
22.53B
from 22.46B
Increased by 0.29%
EPS This Year
22.24
from 16.78
Increased by 32.56%
EPS Next Year
20.56
from 22.24
Decreased by -7.57%
EPS and Forward PE are based on non-GAAP adjusted numbers.